Development of an inactivated vaccine candidate for SARS-CoV-2
2020 · Science · 1,508 citations
https://doi.org/10.1126/science.abc1932
Y
Yanjun Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
293
Papers
11.0K
Citations
40
h-index
143
i10-index
Yanjun Zhang is an academic researcher from Shanxi Medical University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Viral gastroenteritis research and epidemiology & Viral Infections and Vectors. The author has an h-index of 40, co-authored 250 publications.
ORCID: 0000-0002-9597-2050Papers by this author
worksEtiological and epidemiological features of acute respiratory infections in China
2021 · Nature Communications · 488 citations
https://doi.org/10.1038/s41467-021-25120-6
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient
2020 · Emerging Microbes & Infections · 365 citations
https://doi.org/10.1080/22221751.2020.1760144
L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo
2016 · BMC Cancer · 130 citations
https://doi.org/10.1186/s12885-016-2376-0
Rapid development of an inactivated vaccine for SARS-CoV-2
2020 · bioRxiv (Cold Spring Harbor Laboratory) · 77 citations
https://doi.org/10.1101/2020.04.17.046375
Structures of Coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating
2018 · Nature Communications · 58 citations
https://doi.org/10.1038/s41467-018-07531-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat